Department of Endocrine, Nutrition and Metabolic Diseases
Faculty and Staff
| Name | Designation |
|---|---|
| Dr. Arindam Naskar | In-Charge |
| Sri D.K. Das | GDA |
Patient Care Services
OPD service:
- Endocrine, Nutrition and Metabolic diseases OPD (every Tuesday & Friday) at Calcutta School of Tropical Medicine.
- Nutritional counselling, Monitoring and Medical Nutritional Therapy provided all outdoor patients treated in this Department as well as referred from other departments of this institution and other medical institutions.
- Education and awareness regarding diabetes prevention, malnutrition prevention, living healthy life with diabetes, self-blood glucose monitoring, self-insulin administration techniques etc.
- Treatment of diabetic complications like neuropathy, CVD, nephropathy, diabetic foot ulcer etc. with special care.
In patient service:
- Admitting patients to Carmichael Hospital for Tropical Diseases.
- Visiting referred cases by other departments of Calcutta School of Tropical Medicine.
- Metabolic, Endocrinological and Nutritional management to patients treated under other departments.
Routine Indoor & OPD Cases
Indoor (Diabetic patients) | Old OPD Tickets | New OPD Tickets | Total OPD Tickets 35 | 4993 (Male-2631, Female-2362) | 6592 (Male-3426, Female-3166) | 11585
Ongoing Research Activities
| Investigator | Title of the Project |
|---|---|
| Dr. Arindam Naskar | Phase-3 multicenter, randomized, double-blind, double-dummy, parallel-group, active controlled study to compare the efficacy and safety of a fixed dose combination of Metformin Hydrochloride 1000 mg XR, Sitagliptin 100 mg and Pioglitazone 15 mg tablets versus Janumet XR CP (Combipack of Metformin hydrochloride 1000 mg SR and Sitagliptin Phosphate 100 mg) in patients with type 2 Diabetes Mellitus. |
| Dr. Arindam Naskar | Phase-3 multicenter, randomized, double-blind, double-dummy, parallel-group, active controlled study to compare the efficacy and safety of a fixed dose combination of Metformin Hydrochloride 1000 mg XR, Sitagliptin 100 mg and Dapagliflozin 10 mg tablets versus Janumet XR CP (Combipack of Metformin hydrochloride 1000 mg SR and Sitagliptin Phosphate 100 mg) in patients with type 2 Diabetes Mellitus. |
| Dr. Arindam Naskar | Phase-3 multicenter, randomized, double-blind, double-dummy, parallel-group, active controlled study to compare the efficacy and safety of a fixed dose combination of Linagliptin 100 mg and Dapagliflozin 10 mg tablets versus Trajenta 5mg (Linagliptin 5 mg) in patients with type 2 Diabetes Mellitus inadequately controlled on Metformin. |
| Dr. Arindam Naskar | A study on prevalence of albuminuria (micro and macro) in Type 2 Diabetic patients with association of risk factors |
| Dr. Arindam Naskar | Study to determine the prevalence of Non Alcoholic Steato Hepatitis (NASH) and Advanced Fibrosis in patients with Type II Diabetes Mellitus with NAFLD |
| Dr. Arindam Naskar | Cross-sectional study to determine the relationship between iron profile and complications of Diabetes Mellitus in Type2 Diabetes Mellitus patients |
| Dr. Arindam Naskar | Cross-sectional Study to determine the relationship of Red Blood Cell Parameters and Coagulation Profile with HbA1c in Type 2 Diabetes Mellitus patients |
| Dr. Arindam Naskar | Cross sectional study to determine the prevalence of overweight and obesity in type 2 diabetes mellitus patients and its relation to dietary patterns and antidiabetic therapy attending a tertiary care hospital in eastern India |